NMDA radioligands (Kyushu University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNMDA radioligands (Kyushu University)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsEpilepsyAlzheimer DiseaseHuntington Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyushu University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyushu University
Active IndicationsN/A
Inactive IndicationsEpilepsyAlzheimer DiseaseHuntington Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A